These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 13680173)

  • 1. Antimicrobial therapy of unexplained fever in neutropenic patients--guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO), Study Group Interventional Therapy of Unexplained Fever, Arbeitsgemeinschaft Supportivmassnahmen in der Onkologie (ASO) of the Deutsche Krebsgesellschaft (DKG-German Cancer Society).
    Link H; Böhme A; Cornely OA; Höffken K; Kellner O; Kern WV; Mahlberg R; Maschmeyer G; Nowrousian MR; Ostermann H; Ruhnke M; Sezer O; Schiel X; Wilhelm M; Auner HW; ;
    Ann Hematol; 2003 Oct; 82 Suppl 2():S105-17. PubMed ID: 13680173
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Antimicrobial prophylaxis and therapy in neutropenia].
    Link H
    Mycoses; 2003; 46 Suppl 2():21-32. PubMed ID: 15055140
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical guidelines for the management of neutropenic patients with unexplained fever in Japan: validation by the Japan Febrile Neutropenia Study Group.
    Tamura K
    Int J Antimicrob Agents; 2005 Dec; 26 Suppl 2():S123-7; discussion S133-40. PubMed ID: 16249072
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antimicrobial therapy of febrile complications after high-dose chemo-/radiotherapy and autologous hematopoietic stem cell transplantation--guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO).
    Bertz H; Auner HW; Weissinger F; Salwender HJ; Einsele H; Egerer G; Sandherr M; Schüttrumpf S; Südhoff T; Maschmeyer G;
    Ann Hematol; 2003 Oct; 82 Suppl 2():S167-74. PubMed ID: 13680166
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnosis and antimicrobial therapy of pulmonary infiltrates in febrile neutropenic patients--guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO).
    Maschmeyer G; Beinert T; Buchheidt D; Einsele H; Heussel CP; Kiehl M; Lorenz J;
    Ann Hematol; 2003 Oct; 82 Suppl 2():S118-26. PubMed ID: 13680172
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Initial empirical antimicrobial therapy: duration and subsequent modifications.
    Tamura K
    Clin Infect Dis; 2004 Jul; 39 Suppl 1():S59-64. PubMed ID: 15250024
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Empirical antimicrobial therapy in neutropenic patients].
    Maschmeyer G
    Ther Umsch; 1996 Nov; 53(11):854-62. PubMed ID: 8984691
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Febrile neutropenia in haematological malignancies.
    Sharma A; Lokeshwar N
    J Postgrad Med; 2005; 51 Suppl 1():S42-8. PubMed ID: 16519255
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cefepime or carbapenem treatment for febrile neutropenia as a single agent is as effective as a combination of 4th-generation cephalosporin + aminoglycosides: comparative study.
    Tamura K; Matsuoka H; Tsukada J; Masuda M; Ikeda S; Matsuishi E; Kawano F; Izumi Y; Uike N; Utsunomiya A; Saburi Y; Shibuya T; Imamura Y; Hanada S; Okamura S; Gondoh H;
    Am J Hematol; 2002 Dec; 71(4):248-55. PubMed ID: 12447952
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The changing face of febrile neutropenia-from monotherapy to moulds to mucositis. Where do we go from here?
    Pizzo PA
    J Antimicrob Chemother; 2009 May; 63 Suppl 1():i16-7. PubMed ID: 19372174
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of fungal infections in hematology and oncology--guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO).
    Böhme A; Ruhnke M; Buchheidt D; Karthaus M; Einsele H; Guth S; Heussel G; Heussel CP; Junghanss C; Kern WK; Kubin T; Maschmeyer G; Sezer O; Silling G; Südhoff T; Szelényi Dagger H; Ullmann AJ;
    Ann Hematol; 2003 Oct; 82 Suppl 2():S133-40. PubMed ID: 13680170
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Empirical antifungal therapy in patients with neutropenia and persistent or recurrent fever of unknown origin.
    Martino R; Viscoli C
    Br J Haematol; 2006 Jan; 132(2):138-54. PubMed ID: 16398648
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Management of febrile neutropenic patients].
    Takata T; Tamura K
    Gan To Kagaku Ryoho; 2006 Jan; 33(1):13-8. PubMed ID: 16410691
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Central venous catheter (CVC)-related infections in neutropenic patients--guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO).
    Fätkenheuer G; Buchheidt D; Cornely OA; Fuhr HG; Karthaus M; Kisro J; Leithäuser M; Salwender H; Südhoff T; Szelényi H; Weissinger F;
    Ann Hematol; 2003 Oct; 82 Suppl 2():S149-57. PubMed ID: 13680168
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Empirical antimicrobial therapy in neutropenic patients. Results of a multicenter study by the Infections in Hematology Study Group of the Paul Ehrlich Society].
    Maschmeyer G; Link H; Hiddemann W; Meyer P; Helmerking M; Eisenmann E; Schmitt J; Adam D
    Med Klin (Munich); 1994 Mar; 89(3):114-23. PubMed ID: 8196571
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sepsis in neutropenia--guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO).
    Schiel X; Hebart H; Kern WV; Kiehl MG; Sölch JP; Wilhelm S; Ostermann H;
    Ann Hematol; 2003 Oct; 82 Suppl 2():S158-66. PubMed ID: 13680167
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bacteremia in patients with febrile neutropenia after chemotherapy at a university medical center in Malaysia.
    Baskaran ND; Gan GG; Adeeba K; Sam IC
    Int J Infect Dis; 2007 Nov; 11(6):513-7. PubMed ID: 17459753
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An audit of efficacy and toxicity of teicoplanin versus vancomycin in febrile neutropenia: is the different toxicity profile clinically relevant?
    Hahn-Ast C; Glasmacher A; Arns A; Mühling A; Orlopp K; Marklein G; Von Lilienfeld-Toal M
    Infection; 2008 Feb; 36(1):54-8. PubMed ID: 18193385
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnosis and treatment of documented infections in neutropenic patients--recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO).
    Buchheidt D; Böhme A; Cornely OA; Fätkenheuer G; Fuhr HG; Heussel G; Junghanss C; Karthaus M; Kellner O; Kern WV; Schiel X; Sezer O; Südhoff T; Szelényi H;
    Ann Hematol; 2003 Oct; 82 Suppl 2():S127-32. PubMed ID: 13680171
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Infectious Diseases Society of America 2002 guidelines for the use of antimicrobial agents in patients with cancer and neutropenia: salient features and comments.
    Rolston KV
    Clin Infect Dis; 2004 Jul; 39 Suppl 1():S44-8. PubMed ID: 15250020
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.